Introduction

The normal range for the potassium concentration in serum is 3.8 to 4.9 mmol/L and in plasma is 3.4 to 4.5 mmol/L.1

Common causes of hyperkalaemia are listed in Common causes of hyperkalaemia. To avoid inappropriate emergency treatment for hyperkalaemia, the abnormality should be confirmed on a serum sample without obvious haemolysis that has been centrifuged and analysed without delay. Delayed transfer of the sample to the laboratory, especially with cooling to 4 °C (which can provoke in vitro potassium release), is a common cause of pseudohyperkalaemia. In the primary care setting, samples taken later in the day are at particular risk of this effect. The artefact is aggravated by recentrifuging samples.

Note: Haemolysis and delay in transferring serum samples to the laboratory are common causes of pseudohyperkalaemia.

After confirming the diagnosis of hyperkalaemia, assessing acid–base and volume status and kidney function is essential for optimal choice of therapy. The most common cause is chronic kidney disease, followed by a depleted fluid volume. Hyperkalaemia management may require several options for therapy, depending on the clinical context and degree of urgency.

An ECG helps to assess how urgently treatment is needed. Urgent treatment is required if the ECG has changes due to hyperkalaemia (ie peaked T waves progressing to atrial arrest and a broadened QRS complex, indicating that ventricular arrest is likely to occur). This is unusual when the serum potassium concentration is lower than 7 mmol/L.

Table 1. Common causes of hyperkalaemia

Mechanism of high serum potassium concentration

Cause of high serum potassium concentration

pseudohyperkalaemia

haemolysis

blood sample handling (stored, refrigerated, recentrifuged)

thrombocytosis

extreme leucocytosis

kidney failure

reduced potassium excretion

fluid volume depletion

reduced potassium excretion secondary to reduced distal tubular water and sodium delivery

hypoaldosteronism

hyporeninaemia (eg diabetes, interstitial kidney disease)

primary adrenal insufficiency

adrenal enzyme defects

heparin

HIV

resistance to aldosterone action (pseudohypoaldosteronism)

drug-induced

nonsteroidal anti-inflammatory drugs

potassium-sparing diuretic drugs

potassium supplements

trimethoprim

angiotensin converting enzyme inhibitors

angiotensin II receptor blockers

pentamidine

ciclosporin

increased potassium release from cells

metabolic acidosis

insulin deficiency

tissue damage

rhabdomyolysis

other

hyperkalaemic periodic paralysis

Gordon syndrome (with elevated blood pressure)

1 Potassium: plasma or serum. Sydney NSW: The Royal College of Pathologists of Australasia. Accessed 2013, Sep 23.Return